Becker Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.8M | Sell |
490,446
-29,445
| -6% | -$784K | 0.4% | 73 |
|
|
2025
Q4 | $12.9M | Buy |
519,891
+194,028
| +60% | +$4.89M | 0.37% | 71 |
|
|
2025
Q3 | $8.3M | Sell |
325,863
-54,103
| -14% | -$1.34M | 0.24% | 87 |
|
|
2025
Q2 | $9.21M | Sell |
379,966
-534,034
| -58% | -$12.5M | 0.29% | 81 |
|
|
2025
Q1 | $23.2M | Buy |
914,000
+46,145
| +5% | +$1.21M | 0.76% | 49 |
|
|
2024
Q4 | $23M | Sell |
867,855
-85,268
| -9% | -$2.31M | 0.75% | 51 |
|
|
2024
Q3 | $27.6M | Sell |
953,123
-10,640
| -1% | -$310K | 0.9% | 42 |
|
|
2024
Q2 | $27M | Sell |
963,763
-33,818
| -3% | -$931K | 0.93% | 39 |
|
|
2024
Q1 | $27.7M | Buy |
997,581
+16,113
| +2% | +$447K | 0.95% | 37 |
|
|
2023
Q4 | $28.3M | Buy |
981,468
+64,689
| +7% | +$1.96M | 1.02% | 34 |
|
|
2023
Q3 | $30.4M | Sell |
916,779
-40,976
| -4% | -$1.45M | 1.21% | 26 |
|
|
2023
Q2 | $35.1M | Buy |
957,755
+72,328
| +8% | +$2.82M | 1.33% | 20 |
|
|
2023
Q1 | $36.1M | Buy |
885,427
+37,020
| +4% | +$1.6M | 1.43% | 19 |
|
|
2022
Q4 | $43.5M | Buy |
848,407
+4,329
| +0.5% | +$208K | 2.03% | 6 |
|
|
2022
Q3 | $36.9M | Sell |
844,078
-13,795
| -2% | -$670K | 1.94% | 7 |
|
|
2022
Q2 | $45M | Sell |
857,873
-25,008
| -3% | -$1.27M | 2.17% | 6 |
|
|
2022
Q1 | $45.7M | Sell |
882,881
-10,074
| -1% | -$523K | 1.84% | 6 |
|
|
2021
Q4 | $52.7M | Sell |
892,955
-26,861
| -3% | -$1.33M | 2.09% | 7 |
|
|
2021
Q3 | $39.6M | Sell |
919,816
-56,579
| -6% | -$2.51M | 1.67% | 11 |
|
|
2021
Q2 | $38.2M | Buy |
976,395
+10,470
| +1% | +$407K | 1.62% | 12 |
|
|
2021
Q1 | $35M | Buy |
965,925
+13,115
| +1% | +$466K | 1.58% | 14 |
|
|
2020
Q4 | $35.1M | Sell |
952,810
-79,615
| -8% | -$2.92M | 1.73% | 12 |
|
|
2020
Q3 | $35.9M | Sell |
1,032,425
-25,258
| -2% | -$886K | 2% | 7 |
|
|
2020
Q2 | $32.8M | Sell |
1,057,683
-125,062
| -11% | -$4.25M | 1.86% | 11 |
|
|
2020
Q1 | $36.6M | Sell |
1,182,745
-190,951
| -14% | -$6.51M | 2.23% | 11 |
|
|
2019
Q4 | $51.1M | Buy |
1,373,696
+6,295
| +0.5% | +$224K | 1.81% | 13 |
|
|
2019
Q3 | $46.6M | Sell |
1,367,401
-39,958
| -3% | -$1.45M | 1.78% | 16 |
|
|
2019
Q2 | $57.8M | Buy |
1,407,359
+2,282
| +0.2% | +$90.6K | 2.1% | 8 |
|
|
2019
Q1 | $56.6M | Sell |
1,405,077
-125,596
| -8% | -$5.03M | 2.1% | 5 |
|
|
2018
Q4 | $63.4M | Sell |
1,530,673
-130,200
| -8% | -$5.4M | 2.47% | 4 |
|
|
2018
Q3 | $69.4M | Sell |
1,660,873
-47,678
| -3% | -$1.84M | 2.21% | 4 |
|
|
2018
Q2 | $58.8M | Buy |
1,708,551
+37,917
| +2% | +$1.3M | 1.95% | 7 |
|
|
2018
Q1 | $56.3M | Buy |
1,670,634
+94,931
| +6% | +$3.26M | 1.87% | 12 |
|
|
2017
Q4 | $54.1M | Sell |
1,575,703
-14,864
| -0.9% | -$507K | 1.79% | 14 |
|
|
2017
Q3 | $53.9M | Buy |
1,590,567
+23,134
| +1% | +$744K | 1.85% | 12 |
|
|
2017
Q2 | $50M | Buy |
1,567,433
+3,888
| +0.2% | +$123K | 1.79% | 11 |
|
|
2017
Q1 | $50.7M | Buy |
1,563,545
+7,309
| +0.5% | +$230K | 1.85% | 10 |
|
|
2016
Q4 | $48M | Sell |
1,556,236
-176,464
| -10% | -$5.39M | 1.78% | 12 |
|
|
2016
Q3 | $55.7M | Buy |
1,732,700
+36,269
| +2% | +$1.21M | 2.18% | 6 |
|
|
2016
Q2 | $56.7M | Sell |
1,696,431
-186,390
| -10% | -$5.95M | 2.31% | 6 |
|
|
2016
Q1 | $52.9M | Buy |
1,882,821
+14,450
| +0.8% | +$413K | 2.28% | 9 |
|
|
2015
Q4 | $57.2M | Sell |
1,868,371
-57,893
| -3% | -$1.82M | 2.51% | 6 |
|
|
2015
Q3 | $57.4M | Buy |
1,926,264
+21,428
| +1% | +$687K | 2.59% | 3 |
|
|
2015
Q2 | $60.6M | Sell |
1,904,836
-26,246
| -1% | -$855K | 2.38% | 3 |
|
|
2015
Q1 | $63.7M | Buy |
1,931,082
+8,563
| +0.4% | +$272K | 2.48% | 3 |
|
|
2014
Q4 | $56.8M | Buy |
1,922,519
+41,759
| +2% | +$1.2M | 2.21% | 5 |
|
|
2014
Q3 | $52.8M | Buy |
1,880,760
+1,821,571
| +3,078% | +$51.1M | 2.17% | 6 |
|
|
2014
Q2 | $1.67M | Buy |
59,189
+474
| +0.8% | +$13.5K | 0.07% | 87 |
|
|
2014
Q1 | $1.79M | Buy |
58,715
+2,215
| +4% | +$66K | 0.07% | 89 |
|
|
2013
Q4 | $1.64M | Sell |
56,500
-141
| -0.2% | -$4.1K | 0.07% | 90 |
|
|
2013
Q3 | $1.54M | Sell |
56,641
-6,693
| -11% | -$182K | 0.07% | 91 |
|
|
2013
Q2 | $1.68M | Buy |
+63,334
| New | +$1.75M | 0.09% | 83 |
|
Other funds holding PFE
VCM
VPM
Becker Capital Management's PFE Position: Q1 2026 in Review
Becker Capital Management reduced its Pfizer (PFE) stake by 5.7% in Q1 2026, selling an estimated $784K and leaving 490,446 shares worth $13.8M. The position accounts for 0.4% of the portfolio, ranked #73.
Becker Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.4M in Q3 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Becker Capital Management held 490,446 shares of Pfizer worth $13.8M as of Q1 2026.
- Becker Capital Management sold 29,445 Pfizer shares in Q1 2026, an estimated $784K.
- Pfizer made up 0.4% of Becker Capital Management's portfolio in Q1 2026, its #73 holding.
- Becker Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Becker Capital Management's Pfizer position peaked at $69.4M in Q3 2018.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.